TNF-α in Tuberculosis: A Cytokine with a Split Personality

TNF-alpha is an essential component of the innate defence mechanism of the host against pathogenic challenge. Unfortunately, it can also play a major role in the pathology of certain diseases, such as tuberculosis. This disease is a striking example of the role of TNF-alpha as a 'double-edged sword', because apart from its role in controlling the Mycobacterium tuberculosis infection, it can also cause severe tissue damage. TNF-alpha exhibits a very complex network of interactions and many of its activities are still not fully understood. This report aims to review the pivotal role of TNF-alpha in controlling the mycobacterial infection, with a particular emphasis on its influence on chemokine expression and cell movement during granuloma formation, and the issues surrounding the use of TNF-alpha inhibitors for therapeutic use in inflammatory diseases.

[1]  A. Mantovani,et al.  Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection , 2008, The Journal of experimental medicine.

[2]  D. Kirschner,et al.  Tumor Necrosis Factor Blockade in Chronic Murine Tuberculosis Enhances Granulomatous Inflammation and Disorganizes Granulomas in the Lungs , 2008, Infection and Immunity.

[3]  Akira Yamamoto,et al.  Creation and X-ray Structure Analysis of the Tumor Necrosis Factor Receptor-1-selective Mutant of a Tumor Necrosis Factor-α Antagonist* , 2008, Journal of Biological Chemistry.

[4]  R. Wilkinson,et al.  Reduction of Chemokine Secretion in Response to Mycobacteria in Infliximab-Treated Patients , 2007, Clinical and Vaccine Immunology.

[5]  R. Appelberg,et al.  Characterization of the Deregulated Immune Activation Occurring at Late Stages of Mycobacterial Infection in TNF-Deficient Mice1 , 2007, The Journal of Immunology.

[6]  B. Ryffel,et al.  Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection , 2007, The Journal of Immunology.

[7]  K. Oguchi,et al.  TNF-α Drives Human CD14+ Monocytes to Differentiate into CD70+ Dendritic Cells Evoking Th1 and Th17 Responses , 2007, The Journal of Immunology.

[8]  J. Flynn,et al.  Tumor necrosis factor and tuberculosis. , 2007, The journal of investigative dermatology. Symposium proceedings.

[9]  J. Pieters,et al.  Interaction of pathogenic mycobacteria with the host immune system. , 2006, Current opinion in microbiology.

[10]  Jean-Louis Herrmann,et al.  DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis , 2005, PLoS medicine.

[11]  Jun Wang,et al.  Small-Molecule Inhibition of TNF-α , 2005, Science.

[12]  S. Stenger Immunological control of tuberculosis: role of tumour necrosis factor and more , 2005, Annals of the rheumatic diseases.

[13]  Warwick J. Britton,et al.  Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection1 , 2005, The Journal of Immunology.

[14]  J. Ficker,et al.  Inverse Correlation of Maturity and Antibacterial Activity in Human Dendritic Cells1 , 2005, The Journal of Immunology.

[15]  J. Ellner,et al.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. , 2005, The Journal of infectious diseases.

[16]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[17]  J. Flynn,et al.  CCR5-Deficient Mice Control Mycobacterium tuberculosis Infection despite Increased Pulmonary Lymphocytic Infiltration1 , 2004, The Journal of Immunology.

[18]  Simeone Marino,et al.  Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis 1 , 2004, The Journal of Immunology.

[19]  M. Rojas,et al.  Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects. , 2004, The Journal of infectious diseases.

[20]  R S Wallis,et al.  Granulomatous infectious diseases associated with tumor necrosis factor antagonists. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Sher,et al.  MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression , 2004, Infection and Immunity.

[22]  S. Hickman,et al.  Cutting Edge: A New Approach to Modeling Early Lung Immunity in Murine Tuberculosis1 , 2004, The Journal of Immunology.

[23]  B. Gicquel,et al.  TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. , 2004, The Journal of clinical investigation.

[24]  John L. Johnson,et al.  A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis , 2004, AIDS.

[25]  J. Flynn,et al.  In Situ Studyof Abundant Expression of Proinflammatory Chemokines and Cytokines inPulmonary Granulomas That Develop in Cynomolgus MacaquesExperimentally Infected with Mycobacteriumtuberculosis , 2003, Infection and Immunity.

[26]  J. Flynn,et al.  Chemokines and tuberculosis. , 2003, Cytokine & growth factor reviews.

[27]  S. Ehlers,et al.  Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF , 2003, Annals of the rheumatic diseases.

[28]  Eugene A Zhukovsky,et al.  Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants , 2003, Science.

[29]  S. Kaufmann,et al.  Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis , 2003, Nature Medicine.

[30]  P. Haslett,et al.  Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. , 2003, The Journal of infectious diseases.

[31]  R. Long,et al.  Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. , 2003, The Lancet. Infectious diseases.

[32]  J. Ernst,et al.  Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. , 2003, Microbes and infection.

[33]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[34]  P. Selby,et al.  Mycobacterium bovis bacillus Calmette–Guérin‐infected dendritic cells potently activate autologous T cells via a B7 and interleukin‐12‐dependent mechanism , 2003, Immunology.

[35]  B. Samten,et al.  Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  S. Kaufmann,et al.  Protection against tuberculosis: cytokines, T cells, and macrophages , 2002, Annals of the rheumatic diseases.

[37]  N. Reiling,et al.  Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[38]  B. Ryffel,et al.  Toll-Like Receptor 4 Expression Is Required to Control Chronic Mycobacterium tuberculosis Infection in Mice1 , 2002, The Journal of Immunology.

[39]  D. Goeddel,et al.  TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.

[40]  Xiao-Yu Song,et al.  Binding and functional comparisons of two types of tumor necrosis factor antagonists. , 2002, The Journal of pharmacology and experimental therapeutics.

[41]  Andrew G. D. Bean,et al.  TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.

[42]  R. Strieter,et al.  β-Chemokines Are Induced by Mycobacterium tuberculosis and Inhibit Its Growth , 2002, Infection and Immunity.

[43]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[44]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[45]  J. Lafitte,et al.  Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. , 2001, The Journal of allergy and clinical immunology.

[46]  P. Holt Antigen presentation in the lung. , 2000, American journal of respiratory and critical care medicine.

[47]  R M Siegel,et al.  A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. , 2000, Science.

[48]  P. Bardin,et al.  In Situ Production of Gamma Interferon, Interleukin-4, and Tumor Necrosis Factor Alpha mRNA in Human Lung Tuberculous Granulomas , 2000, Infection and Immunity.

[49]  B. Ryffel,et al.  Fatal Mycobacterium bovis BCG infection in TNF-LT-α-deficient mice , 2000 .

[50]  Z. Toossi The inflammatory response in Mycobacterium tuberculosis infection. , 2000, Archivum immunologiae et therapiae experimentalis.

[51]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[52]  A. Aderem,et al.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Keane,et al.  Macrophage apoptosis in mycobacterial infections , 1999, Journal of leukocyte biology.

[54]  J. Friedland,et al.  Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. , 1999, Journal of immunology.

[55]  K. Pfeffer,et al.  Fatal Granuloma Necrosis without Exacerbated Mycobacterial Growth in Tumor Necrosis Factor Receptor p55 Gene-Deficient Mice Intravenously Infected with Mycobacterium avium , 1999, Infection and Immunity.

[56]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[57]  M. Olivier,et al.  TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. , 1999, Journal of immunology.

[58]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[59]  Q. Hamid,et al.  The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. , 1999, Journal of immunology.

[60]  Jason G. Cyster,et al.  Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs , 1999, The Journal of experimental medicine.

[61]  R. Steinman,et al.  Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. , 1998, Science.

[62]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[63]  Christoph Schaniel,et al.  Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation , 1998, European journal of immunology.

[64]  Z. Toossi,et al.  Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. , 1998, American journal of respiratory cell and molecular biology.

[65]  R Bonecchi,et al.  Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. , 1998, Journal of immunology.

[66]  H. Macdonald,et al.  Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. , 1998, Journal of immunology.

[67]  P. Barnes,et al.  Production of Monocyte Chemoattractant Protein 1 in Tuberculosis Patients , 1998, Infection and Immunity.

[68]  J. Ellner,et al.  Expression of Virulence of Mycobacterium tuberculosiswithin Human Monocytes: Virulence Correlates with Intracellular Growth and Induction of Tumor Necrosis Factor Alpha but Not with Evasion of Lymphocyte-Dependent Monocyte Effector Functions , 1998, Infection and Immunity.

[69]  M. Torres,et al.  Cytokine Profiles for Peripheral Blood Lymphocytes from Patients with Active Pulmonary Tuberculosis and Healthy Household Contacts in Response to the 30-Kilodalton Antigen ofMycobacterium tuberculosis , 1998, Infection and Immunity.

[70]  M. Burdick,et al.  Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis , 1997, Infection and immunity.

[71]  A. Kharazmi,et al.  Interferon‐γ Production by Human T Cells and Natural Killer Cells In Vitro in Response to Antigens from the Two Intracellular Pathogens Mycobacterium tuberculosis and Leishmania major , 1997, Scandinavian journal of immunology.

[72]  T. Byrd Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes. , 1997, The Journal of clinical investigation.

[73]  R. Arbeit,et al.  Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. , 1997, Journal of immunology.

[74]  N. Mukaida,et al.  Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. , 1997, American journal of respiratory and critical care medicine.

[75]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[76]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[77]  P. Holt,et al.  Brief Definitive Report Dendritic Cells Are Recruited into the Airway Epithelium during the Inflammatory Response to a Broad Spectrum of Stimuli , 2022 .

[78]  L. Culp,et al.  Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. , 1996, The Journal of clinical investigation.

[79]  Z. Toossi Cytokine circuits in tuberculosis. , 1996, Infectious agents and disease.

[80]  G. Rook,et al.  The pathogenesis of tuberculosis. , 1996, Annual review of microbiology.

[81]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[82]  H. Shiratsuchi,et al.  Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. , 1995, Journal of immunology.

[83]  Z. Toossi,et al.  Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. , 1994, The Journal of infectious diseases.

[84]  G. Kaplan,et al.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.

[85]  S. Carsons,et al.  Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. , 1993, Blood.

[86]  G. Rook,et al.  The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor. , 1992, Immunology.

[87]  S. Carsons,et al.  TNF in combination with GM‐CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages , 1992, Journal of leukocyte biology.

[88]  J. Abrams,et al.  Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. , 1992, Journal of immunology.

[89]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[90]  G. Rook,et al.  Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor , 1991, Infection and immunity.

[91]  S. Sprang The divergent receptors for TNF. , 1990, Trends in biochemical sciences.

[92]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[93]  D. Brenner,et al.  Prolonged activation of jun and collagenase genes by tumour necrosis factor-α , 1989, Nature.

[94]  J. Ellner,et al.  Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens , 1988, Infection and immunity.

[95]  D. Brenner,et al.  Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. , 1988, The Journal of biological chemistry.

[96]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[97]  M. Kaliner,et al.  Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura , 1986, The Journal of experimental medicine.

[98]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[99]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[100]  G. Granger,et al.  Lymphocyte in vitro Cytotoxicity: Specific Release of Lymphotoxin-like Materials from Tuberculin-sensitive Lymphoid Cells , 1969, Nature.